• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2019 年指南研讨会会议记录——优化糖尿病、心血管疾病和肾脏疾病指南流程的策略。

Proceedings of the Guideline Workshop 2019 - Strategies for the optimization of guideline processes in diabetes, cardiovascular diseases and kidney diseases.

机构信息

Department of Internal Medicine I, University Hospital Aachen, RWTH Aachen University, Pauwelsstraße 30, 52074 Aachen, Germany.

Department of Medicine K2, Karolinska Institute, Stockholm, Sweden.

出版信息

Diabetes Res Clin Pract. 2020 Apr;162:108092. doi: 10.1016/j.diabres.2020.108092. Epub 2020 Feb 26.

DOI:10.1016/j.diabres.2020.108092
PMID:32109519
Abstract

The Guideline Workshop 2019, held in October 2019 in Munich, Germany, had the purpose of facilitating discussion on strategies for optimization of guideline processes in diabetes amongst a group of representatives of renown national and international societies in the field of diabetes, cardiology, and nephrology. Results of this panel's discussions are presented in this manuscript and comprise a variety of suggestions for improving the quality and usability of guidelines, as well as to accelerate the development and responsiveness of guidelines to newly published, relevant data from clinical trials such as cardiovascular outcome trials in diabetes mellitus. These include, but are not limited to, recommendations to optimize presentation of content in guidelines, use of the GRADE-approach to rating the quality of evidence to harmonize guidelines, and utilization of digital health technologies to accelerate, streamline, and optimize communication on relevant data and development of clinical guidelines and necessary updates, while reducing costs. Recognizing that achieving alignment in guideline development among various medical organizations will be a long-term process, representatives from cross-sectional medical organizations relevant to cardio-renal metabolic disease and experts in guideline methodology will work together in the future. Among other activities, it is planned to continue the activity and organize a Guideline Workshop in 2020.

摘要

2019 年 10 月在德国慕尼黑举行的指南研讨会的目的是促进糖尿病领域知名的国家和国际学会的代表之间讨论优化糖尿病、心脏病学和肾脏病学领域指南流程的策略。本文件介绍了该小组讨论的结果,提出了多种建议,以提高指南的质量和可用性,并加快指南对临床试验(如糖尿病心血管结局试验)新发布相关数据的反应速度。这些建议包括但不限于优化指南内容呈现方式的建议、使用 GRADE 方法对证据质量进行评级以协调指南,以及利用数字健康技术加速、简化和优化相关数据以及临床指南和必要更新的沟通,同时降低成本。认识到在不同医学组织之间实现指南制定的一致性将是一个长期的过程,来自与心血管-肾脏代谢疾病相关的跨学科医学组织的代表和指南方法学专家将在未来共同合作。作为其他活动的一部分,计划继续开展这项活动,并计划在 2020 年举办一次指南研讨会。

相似文献

1
Proceedings of the Guideline Workshop 2019 - Strategies for the optimization of guideline processes in diabetes, cardiovascular diseases and kidney diseases.2019 年指南研讨会会议记录——优化糖尿病、心血管疾病和肾脏疾病指南流程的策略。
Diabetes Res Clin Pract. 2020 Apr;162:108092. doi: 10.1016/j.diabres.2020.108092. Epub 2020 Feb 26.
2
Proceedings of the Guideline Workshop 2019: Strategies for the Optimization of Guideline Processes in Diabetes, Cardiovascular Diseases, and Kidney Diseases.2019 年指南研讨会会议记录:糖尿病、心血管疾病和肾脏疾病指南流程优化策略。
Diabetes Technol Ther. 2020 Jul;22(7):546-552. doi: 10.1089/dia.2020.0086. Epub 2020 Jun 26.
3
Harmonize care to optimize outcome in children and adolescents with diabetes mellitus: treatment recommendations in Europe.协调照护以优化糖尿病患儿和青少年的结局:欧洲的治疗推荐。
Pediatr Diabetes. 2012 Sep;13 Suppl 16:15-9. doi: 10.1111/j.1399-5448.2012.00908.x.
4
A survey on the methodological processes and policies of renal guideline groups as a first step to harmonize renal guidelines.一项关于肾脏指南制定小组的方法学流程和政策的调查,作为协调肾脏指南的第一步。
Nephrol Dial Transplant. 2015 Jul;30(7):1066-74. doi: 10.1093/ndt/gfu288. Epub 2014 Sep 9.
5
The updated clinical guideline development process in Estonia is an efficient method for developing evidence-based guidelines.爱沙尼亚更新的临床指南制定流程是制定基于证据的指南的有效方法。
J Clin Epidemiol. 2013 Feb;66(2):132-9. doi: 10.1016/j.jclinepi.2012.07.007. Epub 2012 Sep 10.
6
Adherence of published diabetes mellitus practice guidelines to methodologic standards of guideline development.已发表的糖尿病诊疗指南对指南制定方法学标准的遵循情况。
Endocrinol Metab Clin North Am. 2002 Sep;31(3):819-28. doi: 10.1016/s0889-8529(02)00016-6.
7
Implications of American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guidelines on Statin Underutilization for Prevention of Cardiovascular Disease in Diabetes Mellitus Among Several US Networks of Community Health Centers.美国心脏病学会/美国心脏协会(ACC/AHA)胆固醇指南对几种美国社区卫生中心网络中糖尿病患者心血管疾病预防中他汀类药物未充分利用的影响。
J Am Heart Assoc. 2017 Jul 3;6(7):e005627. doi: 10.1161/JAHA.117.005627.
8
Improving adherence to cardiovascular guidelines: realistic transition from paper to patient.提高心血管疾病指南的依从性:从纸质指南到患者的切实转变。
Expert Rev Cardiovasc Ther. 2020 Jan;18(1):41-51. doi: 10.1080/14779072.2020.1717335. Epub 2020 Jan 22.
9
Synthesis, grading, and presentation of evidence in guidelines: article 7 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.指南中证据的综合、分级和呈现:COPD 指南制定中整合和协调工作的第 7 条。美国胸科学会/欧洲呼吸学会工作组报告。
Proc Am Thorac Soc. 2012 Dec;9(5):256-61. doi: 10.1513/pats.201208-060ST.
10
[Development of guideline-based quality indicators: a qualitative study on barriers and facilitating factors from the perspective of S3-guideline authors].[基于指南的质量指标的制定:从S3指南作者角度对障碍和促进因素的定性研究]
Z Evid Fortbild Qual Gesundhwes. 2019 Nov;147-148:34-44. doi: 10.1016/j.zefq.2019.09.001. Epub 2019 Nov 13.

引用本文的文献

1
Challenges and Stimulating Factors for the Incorporation of Economic Considerations in Clinical Practice Guidelines: A Scoping Review.将经济因素纳入临床实践指南的挑战与促进因素:一项范围综述
J Eval Clin Pract. 2025 Feb;31(1):e14264. doi: 10.1111/jep.14264.
2
Data from network meta-analyses can inform clinical practice guidelines and decision-making in diabetes management: perspectives of the taskforce of the guideline workshop.网络荟萃分析数据可为糖尿病管理的临床实践指南和决策提供信息:指南工作组专题组的观点。
Cardiovasc Diabetol. 2023 Oct 13;22(1):277. doi: 10.1186/s12933-023-01993-3.
3
CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes.
CVOT 峰会 2022 报告:心血管、肾脏和血糖结局的新发现。
Cardiovasc Diabetol. 2023 Mar 16;22(1):59. doi: 10.1186/s12933-023-01788-6.
4
Report from the CVOT Summit 2021: new cardiovascular, renal, and glycemic outcomes.2021 年心血管结局试验峰会报告:心血管、肾脏和血糖结局的新发现。
Cardiovasc Diabetol. 2022 Apr 8;21(1):50. doi: 10.1186/s12933-022-01481-0.